Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
EBIATLeasesOther Gross PP&E AdjustmentsShares IssuedShares Outstanding
Ratios

InspireMD (NSPR) Accumulated Depreciation & Amortization (2016 - 2024)

Historic Accumulated Depreciation & Amortization for InspireMD (NSPR) over the last 12 years, with Q4 2024 value amounting to $280.0 million.

  • InspireMD's Accumulated Depreciation & Amortization rose 2068.97% to $280.0 million in Q4 2024 from the same period last year, while for Dec 2024 it was $280.0 million, marking a year-over-year increase of 2068.97%. This contributed to the annual value of $280.0 million for FY2024, which is 2068.97% up from last year.
  • According to the latest figures from Q4 2024, InspireMD's Accumulated Depreciation & Amortization is $280.0 million, which was up 2068.97% from $232.0 million recorded in Q4 2023.
  • InspireMD's Accumulated Depreciation & Amortization's 5-year high stood at $280.0 million during Q4 2024, with a 5-year trough of $151000.0 in Q4 2020.
  • For the 5-year period, InspireMD's Accumulated Depreciation & Amortization averaged around $140.4 million, with its median value being $188.0 million (2022).
  • In the last 5 years, InspireMD's Accumulated Depreciation & Amortization crashed by 443.04% in 2020 and then surged by 1077962.96% in 2022.
  • Over the past 5 years, InspireMD's Accumulated Depreciation & Amortization (Quarter) stood at $151000.0 in 2020, then soared by 1044.37% to $1.7 million in 2021, then skyrocketed by 10779.63% to $188.0 million in 2022, then rose by 23.4% to $232.0 million in 2023, then increased by 20.69% to $280.0 million in 2024.
  • Its last three reported values are $280.0 million in Q4 2024, $232.0 million for Q4 2023, and $188.0 million during Q4 2022.